Ultimately, activation of SREBP proteins (SREBP1 or SREBP2) resulted in the in vitro proliferation of HCC cells and carcinogenesis in mice (Xu et al., 2020b). The gene discussed is SREBF2; the disease is hepatocellular carcinoma.